Established in September 2016 and formally mandated in July 2022, the CTSI Scientific Review Committee (SRC) provides a scientific and feasibility review of non-oncology clinical research to ensure that UCLA clinical research is of the utmost quality. The degree of review required varies based on the type of research, funding, and institutional factors. CTSI SRC review is conducted on those clinical trial protocols that have not already received documented full peer review. 

This scientific review is intended to complement the Institutional Review Board (IRB) review through a detailed review of the required elements of the clinical protocol, statistical applications, adequacy of research staffing, any competing trials, well-constituted data collection forms, and utilization of institutional resources.

The SRC meets on the first and third Wednesdays of every month. Investigators are not required to initiate SRC reviews and there is no application process. All study documentation is collected by the Office of Research Administration (ORA) staff and provided to the SRC for review.  SRC review occurs in parallel with IRB review.

For more information, please visit the Scientific Review Committee webpage.

Last updated
January 3, 2024